JPRN-C000000224
Completed
未知
Investigational study for elderly acute myelocytic leukemia - Investigational study for elderly acute myelocytic leukemia
Conditionsacute myelocytic leukemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- acute myelocytic leukemia
- Sponsor
- Japan Adult Leukemia Study Group
- Enrollment
- 288
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The AML18 Trial is an intensive chemotherapy trial for patients primarily over the age of 60 with AML and High Risk Myelodysplastic disease. This randomised, up to 2000 patient trial will evaluate the effect of adding novel treatment combinations to standard chemotherapy.Acute Myeloid LeukaemiaHigh Risk Myelodysplastic SyndromeMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-002730-21-GBCardiff University2,000
Active, not recruiting
Phase 1
The AML18 Trial is an intensive chemotherapy trial for patients primarily over the age of 60 with AML and High Risk Myelodysplastic disease. This randomised, up to 2000 patient trial will evaluate the effect of adding novel treatment combinations to standard chemotherapy.Acute Myeloid LeukaemiaHigh Risk Myelodysplastic SyndromeMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-002730-21-DKCardiff University2,000
Recruiting
Not Applicable
Treatment outcome in elderly patients with acute myeloid leukemia at Siriraj HospitalThe patients 60 years and older who were diagnosed and know to have acute myeloid leukemia.Treatment outcome in elderly patients with acute myeloid leukemia at Siriraj HospitalTCTR20210514007Siriraj Hospital Mahidol University400
Completed
Not Applicable
Myeloproliferative Neoplasms - AYAs and Elderly: Two Sides of the Same Coin? A multicenter non-interventional study of East German Hematology and Oncology Study Group (OSHO)D47.4D45D47.3OsteomyelofibrosisPolycythaemia veraEssential (haemorrhagic) thrombocythaemiaDRKS00023581Martin-Luther-Universität Halle-Wittenberg127
Completed
Not Applicable
The biology of ageing in relation to acute myeloid leukemia (AML) in older patientsNL-OMON39102niversitair Medisch Centrum Groningen75